CMA recently attended the National Association of Medicaid Director’s (NAMD) Fall Conference in Washington, DC. This well attended conference attracts Medicaid Directors from around the country, providing all an opportunity to discuss new initiatives and technologies. While there, CMA proudly showcased its innovative Value-Based Pharmacy Agreements Platform, powered by Lyfegen. Lyfegen is a leader in value based, cost effective solutions that drive savings while improving health outcomes. The CMA-Lyfegen partnership is an exciting industry development, as it brings together two respected Medicaid technology leaders. This partnership has already produced a greatly needed highly secure and scalable solution the enables Medicaid Programs to reduce their existing spend and actively manage the budgetary impact of new, high-cost treatments.
Pictured (left to right): Simon Amstutz (Lyfegen), Gary Davis (CMA), Girisha Fernando (Lyfegen), Ken Romanski (CMA), Nico Mros (Lyfegen), and Jeff Wendth (CMA)